Chapter 4

Congenital Heart Diseases Affecting the Right Heart

Congenital heart disease (CHD) is the most common type of birth defect worldwide and remains a major cause of illness and mortality among infants and children. Advances in prenatal diagnosis, neonatal intensive care, pediatric cardiac surgery, and adult congenital heart disease management have dramatically improved survival rates over the past several decades. Today, many individuals born with congenital heart defects live well into adulthood, creating new challenges in long-term medical care, imaging, and genetic counseling.

A significant proportion of congenital heart diseases involve the right side of the heart, including the right atrium, right ventricle, pulmonary valve, pulmonary artery, tricuspid valve, and right ventricular outflow tract. These structures originate primarily from the second heart field and neural crest cells during embryonic development. Because these developmental pathways are distinct from those forming the left ventricle, abnormalities affecting the right heart often have unique genetic, anatomical, and physiological characteristics.

Congenital heart disease encompasses a broad spectrum of abnormalities. Some defects are relatively minor and require little or no treatment, while others are life-threatening and demand urgent surgical intervention during infancy. The severity of disease depends not only on the anatomical defect but also on its effect on blood flow, oxygen delivery, cardiac function, and pulmonary circulation.

One of the simplest congenital abnormalities affecting the right heart is atrial septal defect (ASD). During fetal development, the right and left atria communicate through the foramen ovale, allowing oxygen-rich blood from the placenta to bypass the lungs. Normally, this opening closes shortly after birth. Failure of complete closure results in an atrial septal defect, permitting blood to flow from the higher-pressure left atrium into the right atrium.

Small ASDs may remain asymptomatic for decades and are sometimes discovered incidentally during routine medical examinations. Larger defects, however, increase blood flow through the right atrium, right ventricle, and pulmonary arteries, leading to enlargement of these chambers over time. Patients may develop fatigue, reduced exercise capacity, irregular heart rhythms, pulmonary hypertension, or right-sided heart failure later in life if the defect remains untreated.

Another common lesion is the ventricular septal defect (VSD). Although VSDs primarily involve the wall separating the ventricles, they substantially affect right ventricular physiology. Blood passes from the high-pressure left ventricle into the lower-pressure right ventricle, increasing pulmonary blood flow and placing additional volume load on the right heart. Small defects often close spontaneously during childhood, whereas large defects may require surgical or catheter-based closure to prevent irreversible pulmonary vascular disease.

Among the most recognized right heart congenital abnormalities is Tetralogy of Fallot (TOF). This complex condition consists of four anatomical abnormalities occurring together: a ventricular septal defect, obstruction of the right ventricular outflow tract (usually pulmonary stenosis), an overriding aorta, and right ventricular hypertrophy. The severity of symptoms depends largely on the degree of obstruction to blood flow leaving the right ventricle.

Because blood cannot easily reach the lungs, oxygen-poor blood enters the systemic circulation through the ventricular septal defect, causing cyanosis, commonly referred to as “blue baby syndrome.” Children with severe Tetralogy of Fallot may experience cyanotic spells characterized by sudden episodes of profound oxygen deprivation, rapid breathing, and loss of consciousness. Surgical repair, usually performed during infancy, has dramatically improved survival, allowing most patients to reach adulthood with good quality of life.

Pulmonary valve stenosis is another important congenital disorder affecting the right heart. In this condition, narrowing of the pulmonary valve obstructs blood flow from the right ventricle into the pulmonary artery. Mild stenosis may produce no symptoms, while severe obstruction forces the right ventricle to generate much higher pressures than normal. Chronic pressure overload causes right ventricular hypertrophy and may eventually impair cardiac function. Balloon valvuloplasty has become the preferred treatment for many patients because it effectively enlarges the valve opening without requiring open-heart surgery.

At the opposite extreme lies pulmonary atresia, one of the most severe congenital heart defects. In pulmonary atresia, the pulmonary valve fails to form properly, preventing blood from flowing directly from the right ventricle into the pulmonary arteries. Survival after birth depends upon alternative pathways such as the ductus arteriosus, which temporarily supplies blood to the lungs. Newborns with pulmonary atresia require immediate medical stabilization followed by staged surgical reconstruction or catheter-based interventions.

The tricuspid valve may also develop abnormally. One notable condition is Ebstein anomaly, in which the tricuspid valve is displaced downward into the right ventricle during embryonic development. As a result, a portion of the right ventricle functions as part of the right atrium, a phenomenon known as “atrialization.” Patients may present with heart murmurs, cyanosis, arrhythmias, or heart failure depending on the severity of valve dysfunction. Modern imaging techniques, particularly cardiac MRI, allow precise assessment of right ventricular size and tricuspid valve anatomy before treatment planning.

Double-outlet right ventricle (DORV) represents another complex congenital malformation. Normally, the aorta arises from the left ventricle while the pulmonary artery originates from the right ventricle. In DORV, however, both great arteries arise predominantly from the right ventricle. Blood flow depends upon the location of an associated ventricular septal defect, making each patient’s anatomy unique. Surgical correction is carefully tailored to individual anatomical features.

Transposition of the great arteries (TGA) is another serious congenital abnormality involving the right ventricular outflow tract. In complete transposition, the pulmonary artery arises from the left ventricle while the aorta originates from the right ventricle, producing two separate circulatory systems that cannot adequately exchange oxygen. Survival requires communication between the circulations through an atrial septal defect, ventricular septal defect, or patent ductus arteriosus until corrective surgery can be performed. The arterial switch operation, introduced in the late twentieth century, has transformed outcomes for affected infants.

One of the rarest but most severe abnormalities is hypoplastic right heart syndrome, in which the right ventricle remains underdeveloped during fetal life. Depending on the extent of hypoplasia, the right ventricle may be incapable of supporting pulmonary circulation after birth. Management often involves staged reconstructive procedures or, in selected cases, heart transplantation.

Congenital abnormalities also affect the pulmonary arteries themselves. Peripheral pulmonary artery stenosis involves narrowing of one or more pulmonary artery branches, reducing blood flow to portions of the lungs. These lesions may occur in isolation or as part of broader genetic syndromes. Balloon angioplasty or stent implantation is frequently used to restore adequate blood flow.

Several inherited syndromes significantly increase the risk of congenital heart disease affecting the right heart. Down syndrome, caused by trisomy 21, is associated with atrioventricular septal defects and other cardiac malformations. DiGeorge syndrome, resulting from deletion of chromosome 22q11.2, commonly causes conotruncal defects such as Tetralogy of Fallot and interrupted aortic arch. Noonan syndrome frequently includes pulmonary valve stenosis and hypertrophic cardiomyopathy. Recognition of these syndromes is important because patients often require multidisciplinary care involving cardiologists, geneticists, endocrinologists, neurologists, and developmental specialists.

Modern genetics has identified numerous genes involved in right heart development. Variants in genes such as NKX2-5, GATA4, TBX5, TBX3, HAND2, NOTCH1, WNT9B, and several others influence the formation of cardiac chambers, valves, and outflow tracts. Some mutations produce highly penetrant inherited disorders, while many common genetic variants each contribute only modestly to disease susceptibility. The combined effects of numerous variants, together with environmental influences, determine overall risk for many congenital heart diseases.

Environmental factors during pregnancy also influence cardiac development. Poorly controlled maternal diabetes substantially increases the likelihood of congenital heart defects. Maternal rubella infection has historically been associated with pulmonary artery abnormalities and patent ductus arteriosus. Certain medications, alcohol consumption, cigarette smoking, obesity, and nutritional deficiencies may also interfere with normal embryonic heart development. Adequate prenatal care, vaccination, folic acid supplementation, and careful medication management can reduce some of these risks.

Clinical presentation varies considerably depending on the specific defect. Some newborns develop severe cyanosis immediately after birth because insufficient blood reaches the lungs for oxygenation. Others present with heart murmurs, rapid breathing, poor feeding, slow weight gain, excessive sweating during feeding, or recurrent respiratory infections. Mild defects may remain unnoticed until adolescence or adulthood when exercise intolerance, arrhythmias, or heart failure develop.

Diagnosis of congenital heart disease has advanced remarkably over the past few decades. Fetal echocardiography can identify many structural abnormalities before birth, allowing delivery to be planned at specialized cardiac centers. After birth, transthoracic echocardiography remains the first-line imaging technique because it is non-invasive, widely available, and provides real-time assessment of cardiac anatomy and blood flow. Cardiac MRI offers superior evaluation of right ventricular volumes, myocardial function, pulmonary arteries, and postoperative anatomy. Computed tomography provides detailed visualization of vascular structures, while cardiac catheterization remains invaluable for direct pressure measurements and therapeutic interventions.

Treatment strategies depend upon the nature and severity of each defect. Some patients require only periodic observation, while others benefit from medications that reduce heart failure symptoms or control arrhythmias. Interventional cardiology now offers minimally invasive procedures such as balloon valvuloplasty, atrial septal defect closure, pulmonary artery stenting, and transcatheter pulmonary valve implantation. Complex structural abnormalities often require surgical reconstruction performed by specialized congenital cardiac surgeons. Advances in surgical techniques, cardiopulmonary bypass, and postoperative care have dramatically improved long-term survival.

Long-term follow-up is essential because congenital heart disease is increasingly recognized as a lifelong condition rather than a childhood illness. Adults with repaired congenital heart disease may develop arrhythmias, right ventricular dysfunction, pulmonary valve insufficiency, heart failure, or complications related to previous surgeries. Specialized adult congenital heart disease centers provide ongoing surveillance, imaging, exercise assessment, pregnancy counseling, and management of late complications.

Artificial intelligence is beginning to transform the diagnosis and management of congenital heart disease. Deep learning algorithms can automatically analyze echocardiograms and cardiac MRI examinations, accurately measuring right ventricular volumes, ejection fraction, chamber dimensions, and blood flow patterns. These technologies reduce observer variability and enable researchers to study thousands of patients simultaneously. When combined with genomic information, AI-driven imaging may identify previously unrecognized patterns linking specific genetic variants with particular anatomical abnormalities.

The future of congenital heart disease management lies in the integration of developmental biology, genetics, advanced imaging, artificial intelligence, and personalized medicine. As researchers continue to identify the molecular mechanisms governing right heart development, clinicians will be better equipped to predict disease risk, optimize treatment strategies, and improve lifelong outcomes for affected individuals.

Congenital heart diseases affecting the right heart illustrate the extraordinary complexity of human cardiac development. Every chamber, valve, and blood vessel must form in precisely the correct sequence during early embryogenesis. Even small disturbances in these carefully orchestrated processes can produce significant structural abnormalities. Understanding these disorders provides the essential foundation for appreciating the genetic discoveries and advanced imaging technologies that will be explored in the next chapter, where we examine the pivotal role of cardiac magnetic resonance imaging in evaluating right heart anatomy and function.